disease

Preliminary study finds a clue for diagnosing CTE in the living

Lauran NeergaardAP Medical Writer 

Scientists stumbled onto a hint that measuring a toxic protein tied to Alzheimer’s disease just might one day be useful in diagnosing a different brain disease in football players and others who have suffered repeated blows to the head.

Doctors evaluate symptoms such as mood swings and memory loss to try to tell if patients may have CTE, or chronic traumatic encephalopathy, a disease linked to concussions and other brain trauma. But other diseases cause similar symptoms, and a CTE diagnosis can only be confirmed by examining the brain after death.

The new clue involves a protein called tau that normally supports neurons but becomes abnormal in Alzheimer’s, tangling inside those nerve cells. Researchers at Washington University in St. Louis were using autopsy samples to study a tau fragment called eMTBR-tau243 that may help track those tangles when they found something unusual: a patient with high levels of that biomarker even though records showed the person didn’t have Alzheimer’s but advanced CTE instead.

The researchers turned to a larger collection of autopsied brain and other samples, and eventually tested blood stored from 11 people who had been classified as having CTE.

Compared to healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study coauthor Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn’t reliably identify early-stage CTE.

It is an interesting but very preliminary finding, requiring far larger studies to see if there is a real connection, cautioned Dr. Rudolph Castellani, a neuropathologist at Northwestern University who wasn’t involved with the research.

Abnormal tau is found in several brain diseases, many of which can overlap in older adults, adding to the difficulty in teasing apart its role in any one disease, including CTE. Sato, who studies such tauopathies, also stressed much more research is needed.

The findings were published in the medical journal JAMA and presented at a scientific meeting in Japan.

Neergaard writes for the Associated Press.

Source link

‘Days of Our Lives” James Reynolds reveals Parkinson’s diagnosis

Longtime “Days of Our Lives” actor James Reynolds revealed he has been diagnosed with Parkinson’s disease.

Reynolds, who has portrayed Abe Carver on the long-running daytime soap for 45 years, discussed his experiences with the disease and the decision to incorporate his diagnosis into Abe’s storyline in an interview Tuesday with Entertainment Tonight.

“Well, it kind of goes back to when I thought I was hiding it,” Reynolds said in his sitdown with the outlet’s Nischelle Turner. “The writers also wanted to incorporate it because it was obvious. It was obvious. We play life here [on ‘Days’], and there are many other characters who have gone through real-life issues that then are mirrored on the show.”

The interview includes clips of Abe navigating his Parkinson’s diagnosis. While Reynolds admits the storyline is one born a bit out of necessity, he believes his character is well-suited for it.

“I feel like the the value of Abe [is] as a character who overcomes a lot, has tremendous amount of strength, deals with a lot of things with with humor as well as understanding,” the actor said.

Parkinson’s disease is a progressive disorder of the nervous system that affects movement. Symptoms can include problems with balance, uncontrollable shaking of one’s hands and stiffness.

The actor had kept his diagnosis private for “more than a few years,” telling only a few people including his wife and son. So Reynolds previously found himself apologizing as he tried “all these different ways” to unsuccessfully hide his symptoms.

“You could see my hand shaking. You could see different things,” Reynolds said. “You’re playing that game with yourself.”

Reynolds said that his “Days” colleagues have been “super, super just extraordinarily helpful and supportive” since he’s opened up about his diagnosis.

“It couldn’t be a better atmosphere. People are just so wonderful and that makes it a lot easier,” he said. “I do have more energy when I’m at work than in any other place.”

Source link

Investigation launched as first human case of ‘brain disease’ found in EU country popular with UK tourists

The World Health Organisation (WHO) has started research after the man died from animal illness – only detected for first time this summer

The World Health Organisation (WHO) has launched an investigation after the first-ever case of a brain disease was found in an EU country which is a favourite destination for UK tourists. Health officials in France raised the alarm following the first ever known case of Shamonda virus (SHAV) infection in a human.

The person concerned had not travelled outside the country in the preceding 12 months, the WHO said. WHO said: “The case was an immunocompromised older man from eastern France with no travel history during the preceding year. He developed severe neurological illness on 23 September 2026 and was diagnosed with severe encephalitis (brain inflammation). The patient died on 8 October 2026.”

It said there are ‘no previously documented human infections’ of the disease, which normally affects animals such as cattle, sheep, goats and horses. The WHO said: “As only one human case has been reported so far, information on the disease in humans remains limited. In this case, the patient was already seriously ill and experienced additional, brain-related symptoms that were considered to be linked to the Shamonda virus.”

Vector-borne transmission (via a bite from an infected midge) is thought to be the most likely source of infection. Officials are investigating the possibility of food-borne transmission, but said it’s unlikely.

WHO added: “As this is the first documented laboratory-confirmed human infection, WHO considers that the public health risk cannot yet be reliably assessed and recommends continued surveillance and investigation.”

The patient lived in rural eastern France, where animal SHAV transmission has been documented since July 2026, and had not travelled in the preceding year. The patient received multiple blood transfusions between February and October 2026 for his underlying illness.

SHAV was only found for the first time in Europe during the summer of 2026 with confirmed or suspected infections reported in cattle, horses and alpacas in Belgium, France, Germany, the Netherlands and Switzerland.

As of October 21 2026, additional European countries and territories have reported SHAV detections in animals: Austria, Ireland, Jersey, Liechtenstein, Portugal, Slovenia and Spain.

It adds: “This first documented human infection with SHAV in 2026 demonstrates that human infection is possible. However, a single case is insufficient to assess the risk to the general population, including immunocompetent individuals, or to determine the frequency, clinical spectrum or severity of human infection. The route of infection and possible sources of exposure are unknown, though vector-borne transmission is a plausible hypothesis.”

Source link

California Prop. 38 last-minute guide: Immunology, immunotherapy research funding

The Trump administration has frozen, terminated or delayed billions in congressionally approved research grants since last year. Proposition 38 aims to backfill some of that loss by creating a stable source of money to fund immunology and immunotherapy research.

The basics

Proposition 38 would authorize the state to issue $8.4 billion in bonds to fund immunology and immunotherapy research to uncover treatments that help the immune system fight diseases such as cancer and Alzheimer’s disease more efficiently.

The impact

The measure would require at least $4.2 billion of the funds to be used for immunology research on cancer, heart disease and Alzheimer’s. It also would authorize the state to enter a partnership with an immunology and immunotherapy research institute selected by the California Department of Public Health and allocate half of the bond revenue to it. The remaining funds would be used for competitive grants that focus solely on immunology and immunotherapy research.

Californians would take on an increased cost of $500 million to $600 million annually to repay the bond for about 20 years, according to the Legislative Analyst’s Office.

The Yes on 38 campaign says the proposition pays for itself: 10% of all proceeds from the licensing of immunotherapies must be returned to the state to offset the total cost of the bond measure, including interest.

However, it’s difficult to predict whether any research projects will lead to marketable treatments.

Dig deeper

Proposition 38 is backed by organizations including the Michael J. Fox Foundation for Parkinson’s Research and the ALS Assn., as well as a majority of local chapters of Democratic organizations across the state. Supporters say the proposed funding could give those afflicted with chronic illness hope and potentially more options for treatment.

Its opponents have said the proposed criteria for awarding the grant funding would appear to create an extremely small pool of qualified recipients. Only the California Institute for Immunology and Immunotherapy, co-founded by billionaire Gary K. Michelson, would qualify under the proposed criteria, according to No on 38, the campaign against the proposition.

Robin Swanson, spokesperson for the Yes on 38 campaign, said “lots of institutions would qualify for funds under this measure.”

But she said at a virtual news conference in mid-September that it was “very likely” that the California Institute for Immunology and Immunotherapy “will qualify for half of the funds under the current criteria.”

Ultimately, Swanson said, the decision lies with the California Department of Public Health.

More reading

Your guide to Proposition 38: Immunology and immunotherapy research funding (L.A. Times)

An analysis of Prop. 38 (California Legislative Analyst’s Office)

This CA proposition will send $4 billion to a single nonprofit. Who’s behind it? (Cal Matters)

This institute could get $4 billion from a ballot measure. With just three workers, is it ready? (Cal Matters)

Source link

What is Lewy body dementia? About the condition Patrick Stewart had

British actor Patrick Stewart died Wednesday at 86. His spokesperson said Thursday that he died from Alzheimer’s disease and Lewy body dementia.

The two conditions often occur together, said UCLA neurology professor Dr. Keith Vossel, and when that happens, the individual’s decline may be faster.

Lewy body dementia is the second-most-common form of degenerative dementia, behind Alzheimer’s disease, Vossel said. It occurs when a protein called alpha-synuclein aggregates in clumps inside the brain. The condition is under-recognized and under-diagnosed in part because its symptoms can overlap with those of Alzheimer’s.

Other celebrities who suffered from the condition include Robin Williams, who took his own life at 63, and Casey Kasem.

The condition is named after Friedrich H. Lewy, the neurologist who discovered the brain abnormalities in the early 1900s, according to the Alzheimer’s Assn. website.

“Essentially the only way to really diagnose these conditions together is after an autopsy and to see the hallmark features of the diseases under the microscope,” Vossel said.

Lewy body dementia symptoms tend to start with rapid eye movement sleep behavior disorder, such as screaming or kicking during sleep. A sufferer may have rigidity or tremors in one of their arms or legs. And they may experience slowness of movement.

A patient may be diagnosed with Lewy body dementia after also experiencing cognitive symptoms within one year of motor symptoms. Cognitive symptoms could include illusions or hallucinations — some patients report sensing a shadowy figure nearby — and difficulties with problem solving and navigation. The condition is also marked by dramatic fluctuations in alertness that occur within hours of the same day.

Another early feature of Lewy body dementia is anxiety, Vossel said.

By contrast, Alzheimer’s disease typically is associated with memory and language loss, and is more associated with apathy and depression than with anxiety. The course of Alzheimer’s disease is slightly slower than that of Lewy body dementia, according to Vossel.

Lewy body dementia is more common in men than in women. Anyone over the age of 60 is at higher risk of having a degenerative condition. Lewy body dementia is most common in people in their 70s to 80s, he said.

There is currently no cure for Lewy body dementia, which is terminal and progressive. After a diagnosis, people can typically expect to live six to eight years before they need 24-hour care, Vossel said.

But medication can help manage symptoms. Clinical studies have found that cardiovascular fitness can slow the rate of decline, Vossel said.

Those who suspect they have Lewy body dementia symptoms should contact a neurologist or a clinician trained in either geriatric medicine or geriatric psychiatry for an evaluation, Vossel said.

Source link

Marshall Faulk shares Parkinson’s diagnosis, hopes to help others

Marshall Faulk is an extraordinarily active 53-year-old. The first-ballot NFL Hall of Fame running back is the head football coach at Southern University in Baton Rouge, La. He runs a foundation in his name that assists underprivileged youth. He works out. He plays a lot of golf.

And he has Parkinson’s disease.

Faulk revealed his diagnosis on The Caring Neurologist podcast this week, saying he noticed Parkinson’s symptoms on the golf course.

“The rigidity in my hand, just sometimes after I play a lot or I practice a lot,” he said. “I just thought it was normal nerves when putting and stuff like that. But it started to be times where I was playing, but I wasn’t in a match, and it would still do that. I was like, ‘Wow, is that normal?’”

Faulk said he was diagnosed about 18 months ago. An unfailing optimist in his social media dispatches and a fiery truth-teller when addressing his team, the former Rams Super Bowl champion described himself on the podcast as “one of the lucky ones” because he caught the disease early.

“The doctor was like, ‘You need to go get checked,’” he said. “You need to go have X, Y and Z done. You’re at an age, it’s possible; it’s likely that it’s not, but you need to go get checked.’”

He jumped on the phone to speak with other former NFL players who share the diagnosis.

“They told me about some of the symptoms and things they had that they thought [were] just football-related, that it didn’t relate to Parkinson’s in any manner,” Faulk said. “They wish, in those early stages, if they had maybe just known a little earlier, they would be in better shape.”

Former Green Bay Packers greats Brett Favre and Ahman Green currently live with Parkinson’s. So does former quarterback Bernie Kosar.

St. Louis Rams' No. 28 thrusts out his left arm with a football cradled in his right, pushing away a Seattle Seahawks player.

St. Louis Rams’ Marshall Faulk, left, straight-arms Lofa Tatupu of the Seattle Seahawks during a 2005 NFL game.

(Elaine Thompson / Associated Press)

Perhaps the most noteworthy sports figure to battle Parkinson’s was boxing great Muhammad Ali, who died in 2016. Faulk met Ali at a dinner and said on the podcast that he is comforted by the memory.

“He leaned over to me and he whispered, ‘You a bad boy,’” Faulk said. “And then he made a couple other comments. I was like, ‘He’s all there.’ So knowing that, I didn’t look at it like life is going to end.”

Faulk was seemingly indestructible as a player. An All-American at San Diego State, he was drafted second overall by the Indianapolis Colts in 1994 and immediately made an impact, rushing for more than 1,000 yards for the first of seven times and being named NFL rookie of the year.

Faulk was traded to the then St. Louis Rams ahead of the 1999 season and led their “Greatest Show on Turf” offense to a Super Bowl XXXIV victory in January 2000. The following season, Faulk was named NFL MVP. He transitioned to the NFL Network broadcast booth after retiring in 2005 having rushed for 12,279 yards and 100 touchdowns while also catching 767 passes for another 36 touchdowns.

He got into coaching in 2025, joining Deion Sanders’ staff at Colorado. When the opportunity arose to become the head coach at Southern, Faulk didn’t hesitate even though he already had been diagnosed with Parkinson’s.

“I could have stayed at Colorado. I was comfortable. But I’ve never done well in life when comfortable,” he said at his introductory news conference at Southern. “And I’m not gonna lie to you. This is uncomfortable, and I like it.”

The Jaguars, an HBCU school competing in the FCS, are 3-4 in Faulk’s first season after going 2-10 in 2025. Faulk’s messages to his players go beyond football. On Thursday he posted this on Instagram: “Protecting your game goes far beyond avoiding injury.⁠ Protect your body.⁠ Protect your mind.⁠ Protect your circle.⁠ Protect your future.

“The decisions you make away from the field can have just as much impact on your future as what happens between the lines,” he continued. “Choose the people, habits, and environments that move you closer to where you want to go.⁠ Send this to a young athlete who needs this reminder today.⁠”

Helping others is why he decided to open up about his Parkinson’s diagnosis, he told host Dr. Sandeep Thakkar on the podcast.

“I want to help as many people as I can,” he said. “What you want to do with that information is pass it on to the next generation to make sure that they have it better, that they know more. And you’re doing it to leave this world a better place than it was when I got here.”



Source link

Trump signs an order aimed at boosting women’s health research, a plan backed by the first lady

President Trump on Monday directed the federal government to bolster federal research into women’s health, a move pushed by his wife, first lady Melania Trump.

The Republican president signed an executive order that creates a new women’s health division at the National Institutes of Health and a White House task force to focus on the issue. That panel was set to hold its first meeting Monday after the Trumps held a Rose Garden signing ceremony.

“Beginning today we will change the reality of women’s health,” Melania Trump said. “Previous generations fought for women’s rights. Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest.”

The president, who spoke after his wife, said the order will “promote new research and really go after the understudied diseases affecting women.” The order is also intended to promote diagnostic technology and improve treatment.

White House chief of staff Susie Wiles, who recently completed treatment for breast cancer, and Health and Human Services Secretary Robert F. Kennedy Jr. will lead the White House task force. Donald Trump said the task force will coordinate with various federal agencies and programs. The order does not include specific funding goals.

The initiative comes after a series of meetings the first lady had with federal health officials.

The president called it a “historic action” and praised the first lady’s work.

“She’s accomplished so much,” he said before pivoting into unscripted commentary on White House renovations, including the patio stone that now covers what was once the Rose Garden lawn.

Shifting back to women’s health, the president expressed surprise that some of the order’s requirements had not already been imposed.

“Who the hell wouldn’t have a women’s health division?” he said, after recalling that he’d asked Melania Trump, “Are you sure they don’t have that?”

The executive order calls for targeting maternal health, mental health and endometriosis. It also mentions other health concerns and diseases, including Alzheimer’s, osteoporosis, heart disease and stroke.

Melania Trump helped shape the order and the task force in consultation with physicians, White House officials, Kennedy and the Republican president. The initiative adds a new dimension to her policy portfolio as first lady.

In Donald Trump’s second term, the first lady has focused on improving foster care systems and expanding technology and artificial-intelligence access in education. In Trump’s first presidency, the first lady’s signature initiative, Be Best, focused on child well-being, safe social media use and reducing drug abuse.

The White House ceremony comes weeks before Nov. 3 elections and as Donald Trump’s job approval ratings have declined, including among women.

About 4 in 10 independent women supported Trump during the 2024 election against Democrat Kamala Harris and in the pre-presidency period, according to AP-NORC polls. That dropped to around a quarter in the opening months of this midterm election year, the period marked by Trump’s hard-line immigration crackdown in U.S. cities and the opening weeks of the Iran war.

Barrow writes for the Associated Press.

Source link